Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults
Launched by NICOLA GOEKBUGET · Sep 12, 2005
Trial Information
Current as of August 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Burkitt's leukemia or Burkitt's lymphoma or primary mediastinal large B-cell lymphoma or B-precursor lymphoblastic lymphoma or large cell anaplastic lymphoma
- • Age \> 15 years
- • Written informed consent
- Exclusion Criteria:
- • Serious secondary diseases, including psychiatric conditions, under which the required therapy compliance is not to be expected
- • HIV infection
- • Secondary lymphoma following prior chemotherapy/radiotherapy or active second malignancy
- • Known severe allergy to foreign proteins
- • Pre-treatment other than 1 cycle CHOP or similar; \< 1 week of another chemotherapy.
- • Pregnancy or nursing
- • Participation in other studies that interfere with study therapy
About Nicola Goekbuget
Nicola Goekbuget is a dedicated clinical trial sponsor specializing in the development and oversight of innovative therapeutic solutions. With a strong focus on advancing medical research, the organization is committed to ensuring the highest standards of compliance, safety, and efficacy in clinical studies. Leveraging expertise in regulatory affairs and trial management, Nicola Goekbuget fosters collaborative partnerships with research institutions and healthcare professionals to facilitate the successful progression of clinical trials. The sponsor is driven by a mission to enhance patient outcomes and contribute to the advancement of medical science through rigorous and ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Frankfurt, , Germany
Patients applied
Trial Officials
Nicola Goekbuget, Dr. med.
Principal Investigator
University Hospital of Frankfurt (Main)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials